Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic

This study reviews research ethics committee applications for COVID-19–related research at a Chinese hospital in February 2020 to characterize study type, approval rate and review time, reason for revision or denial, and issues with informed consent.

Saved in:
Bibliographic Details
Published in:JAMA 2020-05, Vol.323 (18), p.1844-1846
Main Authors: Zhang, Hui, Shao, Fengmin, Gu, Jianqin, Li, Li, Wang, Yuming
Format: Article
Language:English
Subjects:
Antiviral Agents - therapeutic use
Betacoronavirus
Biomedical Research - standards
Biomedical Research - statistics & numerical data
China - epidemiology
Consent Forms - standards
Consent Forms - statistics & numerical data
Containment of Biohazards - standards
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Epidemics
Ethics
Ethics Committees, Research - standards
Humans
Informed consent
Interferon-alpha - therapeutic use
Letter
Letters
Medical ethics
Medicine, Chinese Traditional - adverse effects
Observational Studies as Topic - statistics & numerical data
Online First
Pandemics
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
Practice Guidelines as Topic - standards
Research Design - standards
Research Design - statistics & numerical data
Research ethics
Research Letter
Sample Size
SARS-CoV-2
Time Factors
World Health Organization
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study reviews research ethics committee applications for COVID-19–related research at a Chinese hospital in February 2020 to characterize study type, approval rate and review time, reason for revision or denial, and issues with informed consent.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2020.4362